The legal firm is currently examining whether Onsemi’s officers or directors breached fiduciary duties or engaged in unlawful business practices during the lead-up to the acquisition. Under the terms of the deal revealed on June 25, Synaptics shareholders are set to receive 1.35 shares of Onsemi stock for every share held. Investors impacted by the sudden decline in valuation are being directed to contact Danielle Peyton at Pomerantz LLP to discuss potential participation in class action litigation.

Pomerantz LLP maintains a history of securities litigation spanning over eight decades. As the firm evaluates the circumstances surrounding the Synaptics transaction, stakeholders remain focused on whether the company provided adequate disclosures to its shareholders before the market responded with a sell-off.